retatrutide triple agonist glp-1 gip glucagon receptor ly3437943 mechanism Beyond GLP -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based Eli Lilly just announced striking

Overall, GLP-1 signaling in TBC does not only affect taste sensation, but triggers the activity of this hormone during the cephalic phase and therefore mediates satiety signals

As part of our reporting on the safety of generic drugs and the track records of the factories that make them, were digging deeper into where your medication is coming from

Serotonin differentially modulates excitatory and inhibitory synaptic inputs to putative sleep-promoting neurons of the ventrolateral preoptic nucleus

The Precision Peptide Genetic Test reveals predispositions in these key peptide pathways, allowing providers to contextualize baseline metabolic risk and individual factors that may influence GLP-1 efficacy or side effect tolerance